Orient et al. included 72 participants in a randomised clinical trial and found that positive ALT responses induced by 4 weeks of GLA 1 therapy could be maintained in a subset of chronic hepatitis C patients receiving at least three injections weekly.50 However, the observed ALT response was not accompanied by significant histological improvement after 6 months of treatment. This evidence concerns the gene GPT and chronic hepatitis C virus infection.